simvastatin has been researched along with Colonic Neoplasms in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 11 (64.71) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors | Studies |
---|---|
Bora, V; Gajjar, S; Patel, BM | 1 |
Liu, Y; Long, Y; Peng, M; Xie, W; Yi, L; Zhang, B | 1 |
Abdel-Naim, AB; Abdulaal, WH; Ahmed, OAA; Aldawsari, HM; Alhakamy, NA; Asfour, HZ; Bakhrebah, MA; Caraci, F; Caruso, G; Eid, BG; Fahmy, UA; Kurakula, M; Mohamed, AI; N Alomary, M; Okbazghi, SZ | 1 |
Chung, N; Jeong, YK; Ju, JE; Kim, MS; Lee, JY; Lee, MS | 1 |
Balick, M; Einbond, LS; Esposti, DD; Ma, H; Redenti, S; Roter, A; Soffritti, M; Wu, HA | 1 |
Li, X; Liu, KX; Wang, XM; Zhang, R; Zheng, XF | 1 |
Michalak, K; Palko-Łabuz, A; Środa-Pomianek, K; Szczęśniak-Sięga, B; Uryga, A; Wesołowska, O | 1 |
Majkowski, M; Michalak, K; Palko-Łabuz, A; Środa-Pomianek, K; Świątek, P; Uryga, A; Wesołowska, O | 1 |
Hu, W; Huang, W; Jiang, L; Li, M; Li, Y; Lu, L; Wu, X; Yuan, D | 1 |
Al-Haidari, AA; Syk, I; Thorlacius, H | 1 |
Dong, X; Huang, Y; Li, C; Li, J; Li, M; Qi, C; Sun, H; Wei, Q; Yang, J | 1 |
Byun, HW; Choi, MH; Hong, EM; Jang, HJ; Jang, J; Kae, SH; Kim, JH; Kim, M; Koh, DH; Lee, J; Park, SW | 1 |
Cho, SJ; Jung, HC; Kim, JM; Kim, JS; Lee, JY; Song, IS | 1 |
Cai, DQ; Kim, DH; Kim, SK; Lee, KJ; Qi, XF; Shim, KY; Teng, YC; Yoon, YS | 1 |
Hardwick, JC; Hommes, DW; Jacobs, RJ; Kodach, LL; Morreau, H; Peppelenbosch, MP; van den Brink, GR; van Wezel, T; Verspaget, HW; Voorneveld, PW; Wildenberg, ME | 1 |
Aldieri, E; Bosia, A; Costamagna, C; Doublier, S; Ghigo, D; Pescarmona, G; Riganti, C | 1 |
Fukaura, Y; Ishikawa, C; Narisawa, T; Tanida, N; Terada, K; Umezawa, A; Yazawa, K | 1 |
17 other study(ies) available for simvastatin and Colonic Neoplasms
Article | Year |
---|---|
Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase 4; Diabetes Mellitus, Type 2; Drug Repositioning; Female; Humans; Male; Simvastatin | 2023 |
Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer.
Topics: Animals; Caspase 1; Colonic Neoplasms; Disease Models, Animal; HCT116 Cells; Humans; Mice; Mice, Nude; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Pyroptosis; Reactive Oxygen Species; Simvastatin | 2023 |
Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Male; Microspheres; Particle Size; Polymethacrylic Acids; Rabbits; Simvastatin | 2020 |
Simvastatin enhances the radiosensitivity of p53‑deficient cells via inhibition of mouse double minute 2 homolog.
Topics: Animals; Colonic Neoplasms; HCT116 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-mdm2; Radiation Tolerance; Random Allocation; Simvastatin; Tumor Stem Cell Assay; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
A transcriptomic analysis of black cohosh: Actein alters cholesterol biosynthesis pathways and synergizes with simvastatin.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cholesterol; Cimicifuga; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rats; Real-Time Polymerase Chain Reaction; Saponins; Signal Transduction; Simvastatin; Transcriptome; Triterpenes | 2018 |
MicroRNA‑192 acts as a tumor suppressor in colon cancer and simvastatin activates miR‑192 to inhibit cancer cell growth.
Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; HCT116 Cells; Humans; MicroRNAs; rab GTP-Binding Proteins; Signal Transduction; Simvastatin | 2019 |
Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclic S-Oxides; Cyclooxygenase 2; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Humans; Inhibitory Concentration 50; Proto-Oncogene Proteins c-bcl-2; Simvastatin; Thiazines; Up-Regulation | 2019 |
The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phenothiazines; Simvastatin | 2019 |
Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Topics: Cell Proliferation; Colonic Neoplasms; Down-Regulation; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kruppel-Like Transcription Factors; Mutation; Neoplasm Invasiveness; Simvastatin; Tumor Suppressor Protein p53; Up-Regulation | 2019 |
HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Topics: Apoptosis; Cell Movement; Cell Proliferation; Chemokine CCL17; Colonic Neoplasms; HT29 Cells; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Polyisoprenyl Phosphates; Prenylation; Receptors, CCR4; rhoA GTP-Binding Protein; Simvastatin | 2014 |
Simvastatin downregulated C35 expression and inhibited the proliferation of colon cancer cells Lovo and HT29 in vitro.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; Neoplasm Proteins; Simvastatin | 2016 |
Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Heme Oxygenase-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Simvastatin | 2016 |
Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
Topics: Animals; Apoptosis; bcl-X Protein; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Cell Growth Processes; Cell Line, Tumor; Colitis; Colonic Neoplasms; Down-Regulation; Drug Synergism; Enzyme Activation; HCT116 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-bcl-2; Simvastatin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells.
Topics: Acetylcysteine; Animals; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Colonic Neoplasms; Glutathione; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Oligopeptides; Oxidative Stress; Polyisoprenyl Phosphates; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Simvastatin | 2010 |
Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; CpG Islands; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; HCT116 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Methylation; Mice; Mice, Inbred Strains; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Simvastatin; Xenograft Model Antitumor Assays | 2011 |
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
Topics: Colonic Neoplasms; Doxorubicin; Drug Synergism; Gene Silencing; HT29 Cells; Humans; NF-kappa B; rhoA GTP-Binding Protein; RNA, Small Interfering; Signal Transduction; Simvastatin | 2008 |
Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Anticarcinogenic Agents; Carcinogens; Cholesterol; Colonic Neoplasms; Dimethylhydrazines; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Mice, Inbred ICR; Pravastatin; Simvastatin | 1994 |